Shanlea Gordon

ORCID: 0000-0003-2615-8060
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Impact on Reproduction
  • Neuroscience of respiration and sleep
  • Prenatal Substance Exposure Effects
  • Vaccine Coverage and Hesitancy
  • Opioid Use Disorder Treatment
  • HIV/AIDS Research and Interventions
  • Neonatal Health and Biochemistry
  • SARS-CoV-2 and COVID-19 Research
  • Migraine and Headache Studies
  • Maternal Mental Health During Pregnancy and Postpartum
  • Menstrual Health and Disorders
  • Stress Responses and Cortisol
  • Cannabis and Cannabinoid Research
  • Family Caregiving in Mental Illness
  • Autism Spectrum Disorder Research
  • COVID-19 and healthcare impacts
  • Misinformation and Its Impacts
  • Pediatric Pain Management Techniques
  • Metabolism and Genetic Disorders
  • Family and Disability Support Research
  • Folate and B Vitamins Research
  • Global Cancer Incidence and Screening
  • Endometriosis Research and Treatment
  • Family Support in Illness

British Columbia Children's Hospital
2020-2024

University of British Columbia
2022-2024

Women's Health Research Institute
2021-2024

B.C. Women's Hospital & Health Centre
2022-2024

Creative Commons
2022

University of Victoria
2022

Amsterdam University Medical Centers
2022

University of Amsterdam
2022

Emma Kinderziekenhuis
2022

University of Colorado Anschutz Medical Campus
2022

Abstract Background The success of any COVID-19 vaccine program ultimately depends on high uptake. This study determined overall intention to receive a and identified factors that predict intentions be vaccinated against in Canada, specifically key priority groups by the American Committee Immunization Practice (ACIP) National Advisory (NACI) for early immunization. Methods Individuals from research cohorts general population British Columbia aged 25–69 were invited complete an online survey...

10.1186/s12889-021-11098-9 article EN cc-by BMC Public Health 2021-05-29

Pyridoxine-dependent epilepsy (PDE-ALDH7A1) is a developmental epileptic encephalopathy characterized by seizure improvement after pyridoxine supplementation. Adjunct lysine reduction therapies (LRTs) reduce the accumulation of putative neurotoxic metabolites with goal to improve outcomes. Our objective was examine association between treatment LRTs and cognitive outcomes.Participants were recruited from within International Registry for Patients Pyridoxine-Dependent Epilepsy August 2014...

10.1212/wnl.0000000000201222 article EN Neurology 2022-08-25

Background: The increased stress the world experienced with coronavirus disease (COVID-19) pandemic affected mental health, disproportionately affecting females. However, how perceived in first year menstrual and menopausal symptoms has not yet been investigated. Objectives: This study evaluates effect that of COVID-19 had on female reproductive health. Methods: Residents British Columbia, Canada, were surveyed online as part Rapid Evidence Study a Provincial Population-Based Cohort for...

10.1177/17455057231199051 article EN cc-by-nc Women s Health 2023-01-01

ABSTRACT Objectives: Neonatal opioid withdrawal syndrome (NOWS) refers to the symptoms a newborn may experience if exposed opioids in utero. Traditional NOWS management involves pharmacological treatments, and admission high acuity unit such as neonatal intensive care (NICU) for continuous cardiorespiratory monitoring due theoretical risk of respiratory depression apnea. This quality assurance project aims demonstrate that current clinical practices at Families Recovery (FIR) BC Women’s...

10.1097/cxa.0000000000000199 article FR cc-by-nc-nd The Canadian Journal of Addiction 2024-03-01

Introduction Cannabis products have been used in the management of headaches adults and may play a role pediatric chronic pain. Canadian pediatricians report increasing use cannabis for headaches, despite no well-controlled studies to inform its dosing, safety, effectiveness. The aim our clinical trial is determine dosing safety Cannabidiol (CBD)-enriched Herbal Extract (CHE) treatment adolescents. Methods analysis Youth, parents, an expert steering committee co-designed this tolerability...

10.1371/journal.pone.0290185 article EN cc-by PLoS ONE 2024-09-20

Background Injectable opioid agonist therapy (iOAT) is the highest-intensity treatment currently available in Canada for individuals with severe use disorder. However, there limited data on iOAT administration perinatal period, no research, practice guidelines, or known reports of breastfeeding iOAT. This article presents first case an individual Case summary We present a pregnant 32-year-old woman from disorder, who stabilized and chose to breastfeed her infant. She presented hospital at 38...

10.1097/adm.0000000000001055 article EN cc-by-nc-nd Journal of Addiction Medicine 2022-08-24

ABSTRACT Introduction COVID-19 vaccination is recommended for people living with HIV (PLWH), among whom social inequities and co-morbidities may drive risks of infection outcome severity. Among a provincial (British Columbia) sample, we determined the prevalence vaccine intention by status assessed socio-demographic, hesitancy, psychological predictors intention. Methods Individuals (25-69y) recruited from province-wide research cohorts completed an online survey examining impacts...

10.1101/2021.08.19.21262249 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-08-22

Objectives Untreated opioid use disorder (OUD) in pregnancy may lead to adverse outcomes for the individual and fetus. Injectable agonist therapy (iOAT) is highest intensity treatment severe refractory OUD currently available; however, research on perinatal administration limited. We present first known case series of 13 pregnant or postpartum participants who received intravenous hydromorphone while admitted Families Recovery (FIR) unit, an in-patient stabilization unit Canada. Methods...

10.1097/adm.0000000000001152 article EN cc-by-nc-nd Journal of Addiction Medicine 2023-02-20

Abstract Background The success of any COVID-19 vaccine program ultimately depends on high uptake. This study determined overall intention to receive a and identified factors that predict intentions be vaccinated against in Canada, specifically key priority groups by the American Committee Immunization Practice (ACIP) National Advisory (NACI) for early immunization. Methods Individuals from research cohorts general population British Columbia aged 25-69 were invited complete an online survey...

10.1101/2021.02.03.21251007 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-02-05

Abstract Introduction Cannabis products have been used in the management of headaches adults and may play a role pediatric chronic pain. Canadian pediatricians report increasing use cannabis for headaches, despite no well-controlled studies to inform its dosing, safety, effectiveness. The aim our clinical trial is determine dosing safety Cannabidiol (CBD)-enriched Herbal Extract (CHE) treatment adolescents. Methods analysis Youth, parents an expert steering committee co-designed this...

10.1101/2023.08.04.23293647 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2023-08-07

Abstract Objective The increased stress the globe has experienced with COVID-19 pandemic affected mental health, disproportionately affecting women. However, how perceived in first year menstrual and menopausal symptoms not yet been investigated. Methods Residents British Columbia, Canada, were surveyed online as part of Rapid Evidence Study a Provincial Population-Based Cohort for Gender Sex (RESPPONSE). A subgroup (n=4171) who assigned female sex at birth (age 25-69) within 6-12 months...

10.1101/2022.07.30.22278213 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-07-31
Coming Soon ...